Pulmocide’s Lead Drug Candidate Opelconazole (PC945) Granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA September 16, 2021
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer September 9, 2021
Two Feng Zhang Lab Alumni Find a New CRISPR Enzyme That Could Take a Big Gulp Out of RNA — and a Raft of Devastating Diseases September 9, 2021
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress August 20, 2021
